Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors
Clinical trial NCT06621563 · RECRUITING
Trial details
- NCT number
- NCT06621563
- Sponsor
- Hansoh BioMedical R&D Company
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-14
- Primary completion
- 2026-03-30
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.